Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Omicron Subvariant Therapeutic Updates

Hear expert insights on ivermectin as a treatment for COVID-19 and evolving information on monoclonal antibodies during the latest omicron wave.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: June 7, 2022

Information on this Educational Activity

Faculty

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, PhD, FAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

La Dra. Cristina Mussini analiza si los antivirales contra la COVID-19 están resultando beneficiosos para la prevención y/o el tratamiento de la COVID persistente, de Clinical Care Options (CCO)

Cristina Mussini, MD Released: December 5, 2022

La dott.ssa Cristina Mussini discute se gli antivirali contro la COVID-19 si stiano dimostrando utili nella prevenzione e/o nel trattamento della Long COVID, da Clinical Care Options (CCO)

Cristina Mussini, MD Released: December 5, 2022

Cristina Mussini, MD Released: December 5, 2022

Dr Jason Farley answers frequently asked questions regarding assessment and management of acute outpatient COVID-19, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN Released: December 2, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings